SCHEMBL17629975

SCHEMBL17629975

CCCc1cc(-n2ccnc2)ccc1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
MAPT P10636 1/20 0.50
CYP3A4 P08684 4/20 0.48
CYP19A1 P11511 3/20 0.48
CYP2D6 P10635 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
ADH5 P11766 2/20 0.46
CYP11B1 P15538 2/20 0.45
CYP11B2 P19099 2/20 0.45
IDO1 P14902 2/20 0.43
ENPP2 Q13822 1/20 0.42
MKNK1 Q9BUB5 1/20 0.42
MKNK2 Q9HBH9 1/20 0.42
NOTUM Q6P988 1/20 0.42
HDAC1 Q13547 1/20 0.42
NCOA3 Q9Y6Q9 1/20 0.41
PDE2A O00408 1/20 0.41
PDE3B Q13370 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27671178 0.83 LMNA (0.54) LMNAMAPTCYP3A4CYP19A1ADH5
SCHEMBL17630098 0.82 CYP3A4 (0.48) LMNAMAPTCYP3A4CYP19A1CYP2D6
SCHEMBL8337179 0.82 CYP3A4 (0.50) LMNAMAPTCYP3A4CYP19A1CYP2D6
SCHEMBL4674986 0.80 PDE4A (0.46) LMNAMAPTCYP3A4CYP19A1CYP2D6
SCHEMBL3490259 0.77 LMNA (0.63) LMNAMAPTCYP3A4CYP19A1CYP11B1
SCHEMBL993223 0.76 LMNA (0.58) LMNAMAPTCYP3A4CYP19A1ADH5
SCHEMBL12310548 0.74 CYP3A4 (0.59) LMNAMAPTCYP3A4CYP19A1CYP2D6
SCHEMBL1449607 0.73 LMNA (0.58) LMNAMAPTCYP3A4CYP19A1CYP2D6
SCHEMBL6259515 0.73 LMNA (0.58) LMNAMAPTCYP3A4CYP19A1ADH5
SCHEMBL14259451 0.73 LMNA (0.58) LMNAMAPTCYP3A4CYP19A1CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016046782-A1 IMIDAZOLE BIARYL COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2016-03-31 WO disclosed